Patent · US Expired

Azeto-imidazo-diazepines

US4407752A · kind A · utility

63Cited by
1References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 30, 1982
Grant dateOct 4, 1983
Priority date
Expiry dateJul 30, 2002

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is presented imidazodiazepines of the formula ##STR1## wherein A together with the two carbon atoms denoted as .alpha. and .beta. is the group ##STR2## R.sup.1 is hydrogen, lower alkyl, lower alkoxymethyl, halogen, nitro or a group of the formula --COOR.sup.4, R.sup.2 is hydrogen, trifluoromethyl or halogen, R.sup.3 is hydrogen, trifluoromethyl, halogen or lower alkyl, R.sup.4 is methyl, ethyl or isopropyl and X is an oxygen or sulphur atom and the carbon atom denoted as .gamma. has the (S)-- or (R,S)-- configuration, and their pharmaceutically acceptable acid addition salts. The compounds are useful in the antagonization of the central-depressant, muscle relaxant, ataxic, blood pressure-lowering and respiratory-depressant properties of 1,4-benzodiazepines which have tranquillizing activity. They can also be used for suppressing the activities on the central nervous system of 1,4-benzodiazepines used in other fields of therapy, for example, of schistosomicidally-active, 1,4-benzodiazepines. Also provided are methods to produce the above compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.